EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study

Nobuki Furubayashi iD, Jiro Tsujita, Azusa Takayama, Yuta Shiraishi, Motonobu Nakamura, Takahito Negishi

Research and Reports in Urology · 2026-06 · Volume 18 · 1-11

DOI: 10.2147/rru.s612372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research and Reports in Urology, 2026-06. Verfasst von Nobuki Furubayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IMDC risk classificationadvanced renal cell carcinomaearly progressive diseaseipilimumablandmark analysisnivolumabnon-clear cell histologyoverall survival

Autor:innen und Institutionen

  • Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

ORCID-Profile: Nobuki Furubayashi

Zitieren

APA

Furubayashi, N., Tsujita, J., Takayama, A., Shiraishi, Y., Nakamura, M., & Negishi, T. (2026). Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study. Research and Reports in Urology, Volume 18, 1-11. https://doi.org/10.2147/rru.s612372

Vancouver

Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study. Research and Reports in Urology. 2026;Volume 18:1-11. doi:10.2147/rru.s612372

BibTeX
@article{Furubayashi2026,
  author = {Furubayashi, Nobuki and Tsujita, Jiro and Takayama, Azusa and Shiraishi, Yuta and Nakamura, Motonobu and Negishi, Takahito},
  title = {Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study},
  journal = {Research and Reports in Urology},
  year = {2026},
  volume = {Volume 18},
  pages = {1--11},
  doi = {10.2147/rru.s612372}
}
Kostenlos starten →